Focus: Applied Cognition is a neurology-focused biotech company developing compounds that target the glymphatic system, a novel mechanism for treating neurological disease. The company operates as a pre-revenue stage biotech with a single clinical program in early development.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Hot — 248 jobs added in 30d
Net +237 (248 new, 11 removed). Aggressive expansion phase.
High-risk, high-upside opportunity best suited for mission-driven scientists willing to accept early-stage biotech instability for novel mechanism experience.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Applied Cognition
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Applied Cognition's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles